A detailed history of Sg Americas Securities, LLC transactions in Arvinas, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 9,860 shares of ARVN stock, worth $221,652. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,860
Previous 86,096 88.55%
Holding current value
$221,652
Previous $2.29 Million 89.4%
% of portfolio
0.0%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

SELL
$23.66 - $32.73 $1.8 Million - $2.5 Million
-76,236 Reduced 88.55%
9,860 $243,000
Q2 2024

Jul 12, 2024

BUY
$24.46 - $40.4 $1.22 Million - $2.01 Million
49,799 Added 137.2%
86,096 $2.29 Million
Q1 2024

May 06, 2024

BUY
$36.38 - $52.31 $1.09 Million - $1.56 Million
29,841 Added 462.22%
36,297 $1.5 Million
Q4 2023

Jan 12, 2024

SELL
$14.19 - $42.33 $454,817 - $1.36 Million
-32,052 Reduced 83.23%
6,456 $266,000
Q3 2023

Oct 13, 2023

SELL
$19.64 - $28.21 $370,803 - $532,604
-18,880 Reduced 32.9%
38,508 $756,000
Q2 2023

Jul 10, 2023

BUY
$21.73 - $31.43 $553,484 - $800,553
25,471 Added 79.8%
57,388 $1.42 Million
Q1 2023

Apr 28, 2023

BUY
$26.15 - $37.26 $834,629 - $1.19 Million
31,917 New
31,917 $872,000
Q3 2022

Oct 31, 2022

BUY
$41.87 - $57.99 $292,420 - $405,002
6,984 Added 23.04%
37,299 $1.66 Million
Q2 2022

Jul 29, 2022

BUY
$36.01 - $74.24 $1 Million - $2.07 Million
27,853 Added 1131.32%
30,315 $1.28 Million
Q1 2022

Apr 29, 2022

SELL
$60.27 - $81.57 $51,108 - $69,171
-848 Reduced 25.62%
2,462 $166,000
Q4 2021

Feb 07, 2022

SELL
$65.85 - $96.21 $1.56 Million - $2.27 Million
-23,623 Reduced 87.71%
3,310 $272,000
Q3 2021

Nov 01, 2021

BUY
$73.2 - $107.87 $1.77 Million - $2.61 Million
24,230 Added 896.41%
26,933 $2.21 Million
Q2 2021

Aug 12, 2021

SELL
$60.45 - $84.26 $301,947 - $420,878
-4,995 Reduced 64.89%
2,703 $208,000
Q1 2021

May 13, 2021

BUY
$58.19 - $91.37 $279,195 - $438,393
4,798 Added 165.45%
7,698 $509,000
Q4 2020

Feb 04, 2021

SELL
$20.19 - $84.93 $2.13 Million - $8.96 Million
-105,473 Reduced 97.32%
2,900 $246,000
Q3 2020

Nov 09, 2020

BUY
$22.99 - $36.34 $2.36 Million - $3.73 Million
102,679 Added 1803.28%
108,373 $2.56 Million
Q2 2020

Jul 20, 2020

BUY
$29.88 - $56.74 $47,001 - $89,252
1,573 Added 38.17%
5,694 $191,000
Q1 2020

Apr 30, 2020

BUY
$33.0 - $54.5 $3,729 - $6,158
113 Added 2.82%
4,121 $166,000
Q4 2019

Jan 28, 2020

BUY
$15.39 - $44.38 $61,683 - $177,875
4,008 New
4,008 $165,000

Others Institutions Holding ARVN

About ARVINAS, INC.


  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.2B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.